Drawing for BIOVISION

USPTO serial 75890840

BIOVISION

Reviewed by CopyMark Law Group

Reg. 2995443Status 710
Filing date
Status date
Registration date
Sep 13, 2005
Examiner
ESTRADA, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIOVISION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB666 3RD AVE 10TH FLNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in science, namely, peptides, proteins, nucleic acids, antibodies, enzymes, growth factors and derivatives thereof, for scientific analytical use, not for medical or veterinary purposes; chemicals used for derivatization of peptides, proteins or nucleic acids used in scientific and medical research; cultures of microorganisms for medical research uses; chemical preparations for medical research usesSECTION 8 - CANCELLEDApr 19, 2005
005Medical, veterinary and pharmaceutical preparations, namely, medicines for diagnosis or treatment of degenerative diseases, various types of cancer, bone diseases, inflammatory diseases or dental treatment; pharmaceutically active substances used in the treatment of degenerative diseases, various types of cancer, bone diseases, inflammatory diseases or dental treatment, namely, peptides, proteins, hormones, growth factors, antibodies or nucleic acids, and derivatives thereof, microbiological for medical diagnostic and laboratory uses, veterinary and pharmaceutical purposes, namely, peptides, proteins, hormones, antibodies or nucleic acids, and derivatives thereof, cultures of microorganisms for medical diagnostic and laboratory uses, veterinary and pharmaceutical purposesSECTION 8 - CANCELLEDApr 19, 2005

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 20, 2012C8..CANCELLED SEC. 8 (6-YR)—
Dec 19, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 18, 2006CORVREVIEW OF CORRESPONDENCE COMPLETE—
Aug 21, 2006MAILPAPER RECEIVED—
Apr 26, 2006ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 13, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 3, 2005REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Jul 29, 2005ALIEASSIGNED TO LIE—
Jul 25, 2005CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 1, 2005SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 22, 2005IUAFUSE AMENDMENT FILED—
Jun 22, 2005EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 7, 2005EX3GSOU EXTENSION 3 GRANTED—
Feb 18, 2005EXT3SOU EXTENSION 3 FILED—
Feb 18, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 17, 2004EX2GSOU EXTENSION 2 GRANTED—
Aug 3, 2004CFITCASE FILE IN TICRS—
Jul 26, 2004EXT2SOU EXTENSION 2 FILED—
Jul 26, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 16, 2004EX1GSOU EXTENSION 1 GRANTED—
Feb 16, 2004EXT1SOU EXTENSION 1 FILED—
Feb 16, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 6, 2003DPCCDIVISIONAL PROCESSING COMPLETE—
Oct 1, 2003FAXXFAX RECEIVED—
Sep 22, 2003MAILPAPER RECEIVED—
Sep 16, 2003DRRRDIVISIONAL REQUEST RECEIVED—
Sep 16, 2003FAXXFAX RECEIVED—
Aug 19, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 27, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 7, 2003NPUBNOTICE OF PUBLICATION—
Sep 4, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 30, 2002CNEAEXAMINERS AMENDMENT MAILED—
Apr 2, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 22, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2002MAILPAPER RECEIVED—
Dec 3, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 1, 2001CNSLLETTER OF SUSPENSION MAILED—
Dec 12, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2000DOCKASSIGNED TO EXAMINER—
Jun 1, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance